drugset
drugset / Trial / NCT00607256

Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

NCT00607256 ↗

Phase 3 Terminated 500 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the lon-term safety and tolerability of \[S,S\]-reboxetine in patients with fibromyalgia

Timeline

Start
2007-10-20
Primary completion
2009-05-18
Completion
2009-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown — —

Indications

fibromyalgia